Hochschulschrift
Characterisation of novel α-galactosidase A mutations in Fabry disease based on in vitro, in vivo and pharmacological data
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Rostock, Universität Rostock. Mathematisch-Naturwissenschaftliche Fakultät, Dissertation, 2014
- Klassifikation
-
Medizin, Gesundheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Rostock
- (wer)
-
Universität Rostock
- (wann)
-
2014
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.18453/rosdok_id00001355
- URN
-
urn:nbn:de:gbv:28-diss2014-0107-1
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Lukas, Jan
- Rolfs, Arndt
- Schröder, Reinhard
- Dichgans, Martin
- Universität Rostock
Entstanden
- 2014
Ähnliche Objekte (12)
![Characterisation of novel α-galactosidase [alpha-galactosidase] A mutations in Fabry disease based on in vitro, in vivo and pharmacological data](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Characterisation of novel α-galactosidase [alpha-galactosidase] A mutations in Fabry disease based on in vitro, in vivo and pharmacological data
Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
Stratification of Fabry mutations in clinical practice: a closer look at α‐galactosidase A‐3D structure
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
Rats deficient in α-galactosidase A develop ocular manifestations of Fabry disease
Hydrophob immobilisierte β-Galactosidase [Beta-Galactosidase]
Lysosomale β-Galactosidase [Beta-Galactosidase] der Rattenleber
Fabry-Münster-Studie (FaMüS) : Diskussion des Fabryzentrum-Münster-Kollektivs und der kardiologischen Effektivität der α-Galactosidase-Ersatz-Therapie [Alpha-Galactosidase-Ersatz-Therapie]
Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies
Affective and cognitive behavior in the alpha-galactosidase A deficient mouse model of Fabry disease
Metagenomic identification, purification and characterisation of the Bifidobacterium adolescentis BgaC β-galactosidase
Characterisation of novel α-galactosidase [alpha-galactosidase] A mutations in Fabry disease based on in vitro, in vivo and pharmacological data
Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
Stratification of Fabry mutations in clinical practice: a closer look at α‐galactosidase A‐3D structure
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
Rats deficient in α-galactosidase A develop ocular manifestations of Fabry disease
Hydrophob immobilisierte β-Galactosidase [Beta-Galactosidase]
Lysosomale β-Galactosidase [Beta-Galactosidase] der Rattenleber
Fabry-Münster-Studie (FaMüS) : Diskussion des Fabryzentrum-Münster-Kollektivs und der kardiologischen Effektivität der α-Galactosidase-Ersatz-Therapie [Alpha-Galactosidase-Ersatz-Therapie]
Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies
Affective and cognitive behavior in the alpha-galactosidase A deficient mouse model of Fabry disease
Metagenomic identification, purification and characterisation of the Bifidobacterium adolescentis BgaC β-galactosidase
Characterisation of novel α-galactosidase [alpha-galactosidase] A mutations in Fabry disease based on in vitro, in vivo and pharmacological data
Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
Stratification of Fabry mutations in clinical practice: a closer look at α‐galactosidase A‐3D structure
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
Rats deficient in α-galactosidase A develop ocular manifestations of Fabry disease
Hydrophob immobilisierte β-Galactosidase [Beta-Galactosidase]
Lysosomale β-Galactosidase [Beta-Galactosidase] der Rattenleber
Fabry-Münster-Studie (FaMüS) : Diskussion des Fabryzentrum-Münster-Kollektivs und der kardiologischen Effektivität der α-Galactosidase-Ersatz-Therapie [Alpha-Galactosidase-Ersatz-Therapie]
Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies
Affective and cognitive behavior in the alpha-galactosidase A deficient mouse model of Fabry disease